Travoprost Ophthalmic Solution USP, 0.004%

Alembic Pharmaceuticals Inc.🇺🇸 United States

FDA Page

Effective Date: Jul 12, 2022
Approval ID: be3bdc10-b5eb-4b4b-9a00-1f8c03ccb3b5
Products: 1 registered
Version: 6

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use TRAVOPROST OPHTHALMIC SOLUTION USP, 0.004% safely and effectively. See full prescribing information for TRAVOPROST OPHTHALMIC SOLUTION USP, 0.004%. TRAVOPROST ophthalmic solution USP 0.004% Initial U.S. Approval: 2001

Quick Stats

Total Products1

Labelers2

Label Sections14

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.